美国食品和药物管理局(FDA)批准了由微生物制备的人α-干扰素的市场销售,使它成为干扰素族中第一个在美国以商品形式出售的干扰素。FDA仅批准此于扰素用于治疗毛细胞性白血病。虽然目前对毛细胞性白血病发病率的估计不同,但在美国,据推测有1,000名患者(主要是中年男子)。在有2,000多名患者参加的国际 The U.S. Food and Drug Administration (FDA) approved the sale of human interferon alpha produced by microorganisms, making it the first interferon family to be sold as a commercial interferon in the United States. The FDA approved only this interferon for the treatment of hairy cell leukemia. Although the current estimate of the incidence of hairy cell leukemia is different, in the United States, it is estimated that there are 1,000 patients (mainly middle-aged men). More than 2,000 patients participated in the international